Introduction Biosimilar monoclonal antibodies (mAbs) are biologic drugs designed to be highly similar to already approved reference monoclonal ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, ...

Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.

In phase 3 SURPASS programme, said the company, efficacy was evaluated for Mounjaro 5mg, 10mg and 15mg used alone or in ...

Mounjaro is approved as an adjunct to a reduced-calorie diet and increased physical activity for adults with an initial body ...

The much-awaited launch of Mounjaro, an injectable drug used to treat obesity, overweight, and type 2 diabetes, has been ...

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...

US pharmaceutical giant Eli Lilly has launched its blockbuster diabetes and weight-loss drug, Mounjaro, in India following ...

The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.

The places where you inject insulin may depend on the type of syringe or prefilled insulin pen you use. You should rotate these injection sites on your skin each time you inject insulin.

随着经济社会发展，物质生活极大丰富，生活方式也在不断改变，2型糖尿病（T2DM）的发病率越来越高，且合并肥胖、高血压、心血管疾病等慢性疾病患者比例增加，需要临床对患者进行综合管理。T2DM病理生理机制复杂，降糖药物通过作用于不同的靶点发挥作用[1]。目前所有降糖药的作用机制均有其局限性，联合机制互补的药物具有更 ...